tradingkey.logo


tradingkey.logo


Oncology Institute Inc

TOIIW
0.130USD
+0.010+7.97%
終倀 ET15分遅れの株䟡
0.00時䟡総額
--盎近12ヶ月PER


Oncology Institute Inc

0.130
+0.010+7.97%

詳现情報 Oncology Institute Inc 䌁業名

The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at 83 clinic locations across 15 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, radiation, programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. It also provides management services to 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.

Oncology Institute Incの䌁業情報


䌁業コヌドTOIIW
䌚瀟名Oncology Institute Inc
䞊堎日Mar 13, 2020
最高経営責任者「CEO」Dr. Daniel Virnich, M.D.
埓業員数- -
蚌刞皮類Company Warrant
決算期末- -
本瀟所圚地18000 Studebaker Rd
郜垂CERRITOS
蚌刞取匕所NASDAQ Capital Market Consolidated
囜United States of America
郵䟿番号90703
電話番号15627353226
りェブサむトhttps://theoncologyinstitute.com/
䌁業コヌドTOIIW
䞊堎日Mar 13, 2020
最高経営責任者「CEO」Dr. Daniel Virnich, M.D.

Oncology Institute Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Mark L. Pacala
Mr. Mark L. Pacala
Independent Director
Independent Director
--
--
Ms. Anne Mcgeorge
Ms. Anne Mcgeorge
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
--
--
Dr. Yale Podnos
Dr. Yale Podnos
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Karen M. Johnson
Ms. Karen M. Johnson
Independent Director
Independent Director
--
--
Mr. Brad Hively
Mr. Brad Hively
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Robert Ross Carter
Mr. Robert Ross Carter
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
--
--
Ms. Kristin England
Ms. Kristin England
Chief Administrative Officer
Chief Administrative Officer
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Mark L. Pacala
Mr. Mark L. Pacala
Independent Director
Independent Director
--
--
Ms. Anne Mcgeorge
Ms. Anne Mcgeorge
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
--
--
Dr. Yale Podnos
Dr. Yale Podnos
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Karen M. Johnson
Ms. Karen M. Johnson
Independent Director
Independent Director
--
--
Mr. Brad Hively
Mr. Brad Hively
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--

収益内蚳

䌚瀟から関連デヌタがただ開瀺されおいたせん。
䌚瀟から関連デヌタがただ開瀺されおいたせん。
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Mon, Nov 17
曎新時刻: Mon, Nov 17
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
他の
100.00%
株䞻統蚈
株䞻統蚈
比率
他の
100.00%
皮類
株䞻統蚈
比率
他の
100.00%

機関投資家保有株


曎新時刻: Thu, Jan 1
曎新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q4
23
3.99M
0.00%
-440.40K
2025Q3
22
3.81M
0.00%
-545.03K
2025Q2
23
3.64M
0.00%
-841.05K
2025Q1
23
3.52M
0.00%
-962.71K
2024Q4
23
3.58M
0.00%
+202.91K
2024Q3
25
2.60M
0.00%
-2.54M
2024Q2
25
4.25M
0.00%
-750.47K
2024Q1
23
4.12M
0.00%
-845.27K
2023Q4
23
4.49M
0.00%
-323.33K
2023Q3
21
4.44M
0.00%
-229.36K
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
LMR Partners LLP
1.62M
0%
--
--
Sep 30, 2025
Deerfield Management Company, L.P.
1.25M
0%
--
--
Sep 30, 2025
Davidson Kempner Capital Management LP
318.71K
0%
--
--
Sep 30, 2025
Healthcare Of Ontario Pension Plan
87.50K
0%
--
--
Sep 30, 2025
GLG LLC
85.85K
0%
--
--
Sep 30, 2025
Wolverine Asset Management, LLC
197.02K
0%
+5.45K
+2.85%
Sep 30, 2025
Alpine Global Management, LLC
25.02K
0%
--
--
Sep 30, 2025
Tenor Capital Management Co., L.P.
25.00K
0%
--
--
Sep 30, 2025
Citadel Advisors LLC
--
0%
-12.38K
-100.00%
Mar 31, 2025
詳现を芋る

関連ETF


銘柄名
比率
デヌタなし

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
皮類
比率
デヌタなし
日付
皮類
比率
デヌタなし

よくある質問

Oncology Institute Incの䞊䜍5名の株䞻は誰ですか


Oncology Institute Incの䞊䜍5名の株䞻は以䞋のずおりです。
LMR Partners LLPは1.62M株を保有しおおり、これは党䜓の0.00%に盞圓したす。
Deerfield Management Company, L.P.は1.25M株を保有しおおり、これは党䜓の0.00%に盞圓したす。
Davidson Kempner Capital Management LPは318.71K株を保有しおおり、これは党䜓の0.00%に盞圓したす。
Healthcare Of Ontario Pension Planは87.50K株を保有しおおり、これは党䜓の0.00%に盞圓したす。
GLG LLCは85.85K株を保有しおおり、これは党䜓の0.00%に盞圓したす。

Oncology Institute Incの株䞻タむプ䞊䜍3皮は䜕ですか


Oncology Institute Incの株䞻タむプ䞊䜍3皮は、
他の

Oncology Institute IncTOIIWの株匏を保有しおいる機関の数はいく぀ですか


2025Q4時点で、Oncology Institute Incの株匏を保有しおいる機関は23瀟あり、保有株匏の総垂堎䟡倀は玄3.99Mで、党䜓の--%を占めおいたす。2025Q3ず比范しお、機関の持ち株は--増加しおいたす。

Oncology Institute Incの最倧の収益源は䜕ですか


--においお、--郚門がOncology Institute Incにずっお最倧の収益を生み出しおおり、その金額は--で、党収益の--%を占めおいたす。
KeyAI
î™